GlassScriptPhysician profile
Windsor Ting
NPI 1386608354
$117,135.14
in general payments reported to CMS, 2019-2025
22 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $15K · 2021: $13K · 2022: $10K · 2023: $7,018 · 2024: $22K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $6,077 · Travel and Lodging: $3,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,045.76 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,600.00 |
| Food and Beverage | $6,076.85 |
| Travel and Lodging | $3,977.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $40,608.92 | 2019-2022 | |
| Boston Scientific Corporation | $39,397.23 | 2019-2025 | Ekosonic, Angiojet Ultra 5000a, Wallstent Rp Endoprosthesis |
| Janssen Scientific Affairs, LLC | $16,900.00 | 2019-2020 | |
| Advanced Oxygen Therapy INC. | $9,494.84 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Bard Peripheral Vascular, INC. | $4,670.72 | 2019-2025 | Venovo |
| Medtronic, INC. | $3,473.55 | 2021-2025 | Abre, Endurant Iis, Hawkone |
| Medtronic Vascular, INC. | $571.39 | 2019 | |
| Philips North America LLC | $498.69 | 2022-2024 | (6554) Peripheral Vascular Undivided, (Br5) Peripheral Ivus |
| W. L. Gore & Associates, INC. | $349.37 | 2019-2025 | Product In Development, Viatorr Endoprosthesis |
| Inari Medical, INC. | $245.21 | 2022 | |
| Abbott Laboratories | $184.81 | 2023 | Jeti |
| Penumbra, INC. | $181.26 | 2023-2025 | Penumbra System, Indigo System |
| Bolton Medical INC | $173.11 | 2022 | |
| Stryker Corporation | $166.65 | 2025 | Clottriever Bold Catheter, Revcore Thrombectomy Catheter |
| Angiodynamics, INC. | $75.15 | 2023-2025 | Venacure 1470 Pro |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $48.86 | 2019 | |
| Cordis US Corp. | $27.05 | 2025 | Mynx Control Venous |
| Lemaitre Vascular, INC. | $24.63 | 2025 | Artegraft Vascular Graft |
| Smith+Nephew, INC. | $16.46 | 2023 | Collagenase Santyl |
| Tactile Systems Technology INC | $16.03 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $11.21 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Windsor Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.